Clementine, a Netherlands-based healthtech startup, has raised €1.7 million ($2 million) in seed funding to advance its artificial intelligence platform designed to improve how people with hearing loss connect with healthcare services.
The funding round was led by Healthy.Capital, an investment firm focused on digital health innovations. The capital injection will allow Clementine to deepen its AI capabilities while expanding partnerships with hearing clinics, optical retailers, and other healthcare organizations across Europe.
Addressing a Healthcare Gap
The Dutch startup addresses a specific challenge within hearing healthcare: converting clinical leads into actual patient engagement. Clementine’s platform leverages artificial intelligence to streamline this process, helping hearing care providers better identify and communicate with individuals who could benefit from their services.
Founded in 2024, Clementine has already attracted attention from the investment community for its focused approach to a substantial market opportunity. Approximately 1.5 billion people globally experience some form of hearing loss, yet many remain undiagnosed or untreated due to barriers in patient discovery and engagement.
Strategic Backing and Vision
Douwe Jippes, Managing Partner at Healthy.Capital, expressed confidence in the startup’s trajectory: “Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with hearing healthcare. And that’s impact we like to help scale.”
The investment reflects broader trends within European healthtech, where artificial intelligence is increasingly deployed to solve operational and patient-engagement challenges across medical specialties. Hearing care, in particular, represents an underserved sector where digital tools can significantly improve outcomes.
European Healthtech Momentum
Clementine’s funding success follows a period of sustained investment in health-focused artificial intelligence across Europe. The continent has emerged as a hub for healthtech innovation, with startups addressing everything from diagnostic support to patient management and clinical operations.
The Maastricht-based company operates within a competitive but growing space of AI-driven healthcare solutions. Unlike consumer-focused hearing aid applications, Clementine positions itself as a business-to-business platform aimed at professional hearing care providers seeking to optimize their patient pipelines and operational efficiency.
The startup’s focus on partnership expansion suggests a go-to-market strategy centered on collaboration with existing healthcare infrastructure rather than direct-to-consumer disruption. This approach may reduce regulatory friction while enabling faster market penetration across multiple European healthcare systems.
With its seed funding secured, Clementine joins a cohort of early-stage European healthtech companies attracting institutional capital to scale solutions addressing persistent healthcare gaps. The startup’s development will likely influence broader discussions around AI integration within hearing care and similar clinical specialties facing patient-engagement challenges.